In diseases with complex etiologies and heterogeneity, such as HCC, these gene signatures, which were composed of multiple genes, demonstrated greater reliability compared to biomarkers such as AFP, PD-L1, and TMB (53). Here, AFP is linked to hepatocellular carcinoma.